GL1X · GenesisL1 explorer

Research workbench

8FY0: E3:PROTAC:target ternary complex structure (VCB/753b/BCL-xL)

Analyse 8FY0: E3:PROTAC:target ternary complex structure (VCB/753b/BCL-xL) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
8FY0
Type
protein
Length
485 residues
Chains
4
Method
x-ray diffraction
Authors
Olsen, S.K., Nayak, D., Lv, D., Yuan, Y., Zhang, P., Hu, W., Lv, Z., Sung, P., Hromas, R., Zheng, G., Zhou, D.
Deposited
01/25/23
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.94
Source
Homo sapiens
Molecule
von Hippel-Lindau disease tumor suppressor; Elongin-B; Elongin-C; Bcl-2-like protein 1
UniProt
P40337, Q15370, Q15369, Q07817
Ligands
CAD, YF8
Pockets
2 · best druggability 0.58

Structure

x-ray diffraction · resolution 2.94 · 4 distinct chains · 43% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
Avon Hippel-Lindau disease tumor suppressorprotein14723% helix, 29% strandP40337
BElongin-Bprotein10521% helix, 38% strandQ15370
CElongin-Cprotein8947% helix, 15% strandQ15369
DBcl-2-like protein 1protein14476% helix, 0% strandQ07817

Ligands and binding sites

  • CAD · Cacodylic acid · ligand · chains A
  • YF8 · N-[8-(4-{[(1R,3R,4S)-4-(4-chlorophenyl)-1-methyl-3-{[4-(4-{[4-{[(2R)-4-(morpholin-4-yl)-1-(phenylsulfanyl)butan-2-yl]amino}-3-(trifluoromethanesulfonyl)benzene-1-sulfonyl]carbamoyl}phenyl)piperazin-1-yl]methyl}cyclohexyl]methyl}piperazin-1-yl)-8-oxooctanoyl]-3-methyl-L-valyl-(4R)-4-hydroxy-N-{(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl}-L-prolinamide · ligand · chains A, D
  • GOL · Glycerol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12850.580.7735empty
21320.410.7521empty

Interfaces

4 interfaces between chains.

  • B–C · 1151 Ų buried · 14 hydrogen bonds · protein-protein
  • A–C · 1054 Ų buried · 12 hydrogen bonds · protein-protein
  • A–B · 194 Ų buried · 1 hydrogen bond · protein-protein
  • A–D · 183 Ų buried · 6 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 modified (oxidation).

Compared structures

  • P40337 · AlphaFold monomer V2.0 prediction for von hippel-lindau disease tumor suppressor (P40337) · a predicted model of the same protein · chain A against A, TM-score 0.99
  • Q15370 · AlphaFold monomer V2.0 prediction for elongin-B (Q15370) · a predicted model of the same protein · chain B against A, TM-score 0.99
  • Q15369 · AlphaFold monomer V2.0 prediction for elongin-C (Q15369) · a predicted model of the same protein · chain C against A, TM-score 0.98
  • Q07817 · AlphaFold monomer V2.0 prediction for BCL-2-like protein 1 (Q07817) · a predicted model of the same protein · chain D against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.